查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲基因測序市場：按產品、最終用戶和國家進行的分析和預測（2024-2033 年）
市場調查報告書
商品編碼
1637364

歐洲基因測序市場：按產品、最終用戶和國家進行的分析和預測（2024-2033 年）

Europe Genome Sequencing Market: Focus on Product, End User, and Country - Analysis and Forecast: 2024-2033
出版日期: | 出版商: BIS Research | 英文 67 Pages | 商品交期: 1-5個工作天內

價格

歐洲基因測序市場預計將從 2024 年的 22.2 億美元成長到 2033 年的 72.3 億美元，預測期內的複合年成長率為 14.04%。

基因測序是確定生物體 DNA 完整序列的過程，使科學家能夠破解其整個基因組成。該過程有助於識別基因變異及其對健康和疾病的潛在影響。歐洲基因測序市場正在不斷擴大，原因包括定序成本下降、基因組檢測的普及以及對使用次世代定序技術的產前和新生兒篩檢計畫的需求不斷成長等因素。

長讀定定序的應用日益廣泛，它為複雜的遺傳訊息提供了更詳細和準確的洞察，進一步推動了市場的成長。此外，歐洲各地政府對基因測序計劃的投資和舉措正在大幅提高基因組定序的可近性和採用率。

主要市場統計數據
預測期 2024-2033
2024 年評估 22.2億美元
2033 年預測 72.3億美元
複合年成長率 14.04％

隨著人們對醫療保健的日益關注和精準醫療的發展，基因測序正在成為改善診斷、個人化治療和疾病預防的重要工具。這些趨勢預計將塑造歐洲基因測序市場的未來，確保持續的技術創新和更廣泛的消費者使用機會。

基因檢測需求的不斷成長、精準醫療的應用日益廣泛以及定序技術的不斷進步是推動歐洲基因測序市場顯著成長的因素之一。基因測序，也就是對生物體整個 DNA 序列的確定，正在成為研究、診斷和個人化醫療中越來越重要的工具。

市場區隔

細分一：按產品

  • 套件
  • 裝置
  • 軟體

細分 2：按最終用戶

  • 製藥和生物技術公司
  • 醫院和診斷實驗室
  • 大規模定序組織
  • 研究和學術機構
  • 其他

細分 3：按地區

  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 義大利
    • 法國
    • 其他

本報告研究了歐洲基因測序市場，並提供了關鍵趨勢、市場影響因素分析、法律制度、技術發展和專利趨勢、市場規模趨勢和預測以及各細分市場和主要國家的詳細資訊。競爭格局以及主要企業簡介。

目錄

執行摘要

範圍和定義

第 1 章歐洲基因測序市場：產業分析

  • 主要趨勢：當前和未來的影響評估
    • 將人工智慧和機器學習融入基因測序定序
    • 主要企業之間的夥伴關係、聯盟和擴張日益增多
  • 監管分析
  • 價值和供應鏈分析

2. 歐洲基因測序市場：未來展望

  • 專利分析
    • 專利分析（按年份）
    • 專利分析（按國家）
  • 競爭性基準化分析
    • 市場佔有率
    • 品牌知名度
  • 臨床實施順序
  • 未來展望

第3章基因測序市場（按地區）

  • 區域概況
  • 推動要素與限制因素
  • 歐洲
    • 區域概況
    • 市場成長推動要素
    • 市場問題
    • 按產品
    • 按最終用戶
    • 德國
    • 英國
    • 西班牙
    • 義大利
    • 法國
    • 其他

第 4 章基因測序市場：競爭基準化分析與公司簡介

  • 關鍵策略和發展
    • 夥伴關係、合作和業務擴展
    • 法律法規
    • 新服務
    • M&A
    • 資金籌措活動
  • 公司簡介
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche Ltd.
    • OncoDNA
    • Oxford Nanopore Technologies plc
    • QIAGEN NV

第5章調查方法

Product Code: BHP2487SS

Introduction to Europe Genome Sequencing Market

The Europe genome sequencing market was valued at $2.22 billion in 2024 and is expected to reach $7.23 billion by 2033, growing at a CAGR of 14.04% between 2024 and 2033. Through the process of identifying the entire sequence of an organism's DNA, genome sequencing allows scientists to decipher its entire genetic composition. This process helps identify genetic variations and their potential impact on health and disease. The genome sequencing market in Europe is expanding due to factors such as the decreasing cost of sequencing, increasing adoption of genome testing, and the growing demand for prenatal and newborn screening programs that leverage next-generation sequencing technologies.

The expanding applications of long-read sequencing, which provide more detailed and accurate insights into complex genetic information, further drive market growth. In addition, government investments and initiatives in genome sequencing projects across Europe have significantly boosted accessibility and adoption.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$2.22 Billion
2033 Forecast$7.23 Billion
CAGR14.04%

As the area keeps its attention on developments in healthcare and precision medicine, genome sequencing is becoming a critical tool for improving diagnostics, personalized treatments, and disease prevention. These trends are set to shape the future of the genome sequencing market in Europe, ensuring continued innovation and wider consumer access.

Market Introduction

The growing demand for genetic testing, the growing use of precision medicine, and improvements in sequencing technologies are all contributing to the notable growth of the European genome sequencing market. An increasingly important tool in research, diagnostics, and individualized healthcare is genome sequencing, which decodes an organism's entire DNA sequence.

As next-generation sequencing (NGS) becomes more widely available and sequencing costs decline, the technology becomes more accessible, facilitating its integration into European healthcare systems. Prenatal and neonatal screening, cancer diagnosis, rare disease detection, and pharmacogenomics are important uses.

The market is being further stimulated by government programs and investments in genomic research projects, such as the UK's 100,000 Genomes Project. More precise and thorough genetic analysis is now possible thanks to the growing use of long-read sequencing technologies, improving clinical outcomes.

As Europe continues to prioritize innovation in healthcare, the genome sequencing market is set to play a pivotal role in advancing medical research and delivering personalized treatments.

Market Segmentation

Segmentation 1: by Product

  • Kits
  • Instruments
  • Software

Segmentation 2: by End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Population Sequencing Organizations
  • Research and Academic Institutes
  • Others

Segmentation 3: by Region

  • Europe
    • Germany
    • U.K.
    • Spain
    • Italy
    • France
    • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe genome sequencing market has been segmented based on various categories, such as by product, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe genome sequencing market is a highly fragmented market, with many public and few private companies. Key players in the genome sequencing market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Eurofins Scientific S.E.
  • F. Hoffmann-La Roche Ltd.
  • OncoDNA
  • Oxford Nanopore Technologies plc
  • QIAGEN N.V.

Table of Contents

Executive Summary

Scope and Definition

1 Europe Genome Sequencing Market: Industry Analysis

  • 1.1 Key Trends: Current and Future Impact Assessment
    • 1.1.1 Integration of Artificial Intelligence and Machine Learning in Genome Sequencing
    • 1.1.2 Increasing Partnerships, Alliances, and Business Expansions among Key Players
  • 1.2 Regulatory Analysis
  • 1.3 Value and Supply Chain Analysis

2 Europe Genome Sequencing Market: Future Outlook

  • 2.1 Patent Analysis
    • 2.1.1 Patent Analysis (by Year)
    • 2.1.2 Patent Analysis (by Country)
  • 2.2 Competitive Benchmarking
    • 2.2.1 Market Share
    • 2.2.2 Brand Recognition
  • 2.3 Sequencing Clinical Adoption
  • 2.4 Future Outlook

3 Genome Sequencing Market (By Region)

  • 3.1 Regional Summary
  • 3.2 Drivers and Restraints
  • 3.3 Europe
    • 3.3.1 Regional Overview
    • 3.3.2 Driving Factors for Market Growth
    • 3.3.3 Factors Challenging the Market
    • 3.3.4 By Product
    • 3.3.5 By End User
    • 3.3.6 Germany
      • 3.3.6.1 By Product
    • 3.3.7 U.K.
      • 3.3.7.1 By Product
    • 3.3.8 Spain
      • 3.3.8.1 By Product
    • 3.3.9 Italy
      • 3.3.9.1 By Product
    • 3.3.10 France
      • 3.3.10.1 By Product
    • 3.3.11 Rest-of-Europe
      • 3.3.11.1 By Product

4 Genome Sequencing Market - Competitive Benchmarking and Company Profiles

  • 4.1 Key Strategies and Development
    • 4.1.1 Partnerships, Alliances, and Business Expansions
    • 4.1.2 Regulatory and Legal Activities
    • 4.1.3 New Offerings
    • 4.1.4 Mergers and Acquisitions
    • 4.1.5 Funding Activities
  • 4.2 Company Profiles
    • 4.2.1 Eurofins Scientific S.E.
      • 4.2.1.1 Overview
      • 4.2.1.2 Top Products and Services
      • 4.2.1.3 Top Competitors
      • 4.2.1.4 Key Personnel
      • 4.2.1.5 Analyst View
    • 4.2.2 F. Hoffmann-La Roche Ltd.
      • 4.2.2.1 Overview
      • 4.2.2.2 Top Products and Services
      • 4.2.2.3 Top Competitors
      • 4.2.2.4 Key Personnel
      • 4.2.2.5 Analyst View
    • 4.2.3 OncoDNA
      • 4.2.3.1 Overview
      • 4.2.3.2 Top Products and Services
      • 4.2.3.3 Top Competitors
      • 4.2.3.4 Key Personnel
      • 4.2.3.5 Analyst View
    • 4.2.4 Oxford Nanopore Technologies plc
      • 4.2.4.1 Overview
      • 4.2.4.2 Top Products and Services
      • 4.2.4.3 Top Competitors
      • 4.2.4.4 Key Personnel
      • 4.2.4.5 Analyst View
    • 4.2.5 QIAGEN N.V.
      • 4.2.5.1 Overview
      • 4.2.5.2 Top Products and Services
      • 4.2.5.3 Top Competitors
      • 4.2.5.4 Key Personnel
      • 4.2.5.5 Analyst View

5 Research Methodology

  • 5.1 Data Sources
    • 5.1.1 Primary Data Sources
    • 5.1.2 Secondary Data Sources
    • 5.1.3 Data Triangulation

List of Figures

  • Figure 1: Europe Genome Sequencing Market, $Billion, 2024, 2028, and 2033
  • Figure 2: Genome Sequencing Market (by Region), $Billion, 2023, 2027, and 2033
  • Figure 3: Europe Genome Sequencing Market (by End User), $Billion, 2023, 2027, and 2033
  • Figure 4: Europe Genome Sequencing Market (by Product), $Billion, 2023, 2027, and 2033
  • Figure 5: Key Players' Strategic Priorities
  • Figure 6: Potential Future Directions
  • Figure 7: Companies Utilizing Artificial Intelligence in Genomics
  • Figure 8: Share of Partnerships, Alliances, and Business Expansions vs Other Strategies
  • Figure 9: Some of the Key Partnerships, Alliances, and Business Expansions and their Impact on the Sequencing Market
  • Figure 10: Value and Supply Chain Analysis, Genome Sequencing Market
  • Figure 11: Genome Sequencing Market, Patent Analysis (by Year), January 2021-December 2023
  • Figure 12: Genome Sequencing Market, Patent Analysis (by Country), January 2021-December 2023
  • Figure 13: Europe Genome Sequencing Market, Market Share, 2023
  • Figure 14: Clinical Utility of Genome Sequencing
  • Figure 15: Future Outlook for Genome Sequencing
  • Figure 16: Germany Genome Sequencing Market, $Billion, 2023-2033
  • Figure 17: U.K. Genome Sequencing Market, $Billion, 2023-2033
  • Figure 18: Spain Genome Sequencing Market, $Billion, 2022-2023
  • Figure 19: Italy Genome Sequencing Market, $Billion, 2023-2033
  • Figure 20: France Genome Sequencing Market, $Billion, 2023-2033
  • Figure 21: Partnerships, Alliances, and Business Expansions Activities, January 2020-April 2024
  • Figure 22: Regulatory and Legal Activities, January 2020-April 2024
  • Figure 23: New Offerings, January 2020-April 2024
  • Figure 24: Mergers and Acquisitions, January 2020-April 2024
  • Figure 25: Funding Activities, January 2020-April 2024
  • Figure 26: Data Triangulation
  • Figure 27: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Genome Sequencing Market, Market Opportunities
  • Table 3: Current and Future Impact of Trends
  • Table 4: Regulatory Landscape (by Country)
  • Table 5: Comparison of Some of the Key Sequencers
  • Table 6: Genome Sequencing Market (by Region), $Billion, 2023-2033
  • Table 7: Europe Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 8: Canada Genome Sequencing Market (by End User), $Billion, 2023-2033
  • Table 9: Germany Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 10: U.K. Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 11: Spain Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 12: Italy Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 13: France Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 14: Rest-of-Europe Genome Sequencing Market, $Billion, 2023-2033
  • Table 15: Rest-of-Europe Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 16: Europe Genome Sequencing Market, Key Development Analysis, January 2020-April 2024